Exploring the Therapeutic Rationale for Angiogenesis Blockade in Cervical Cancer

Clinical Therapeutics - United States
doi 10.1016/j.clinthera.2014.11.012
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Elsevier BV

Related search

Targeting Angiogenesis in Advanced Cervical Cancer

Therapeutic Advances in Medical Oncology
Oncology
2014English

Triple Threat to Cancer: Rationale for Combining Oncolytic Viruses, MEK Inhibitors, and Immune Checkpoint Blockade

OncoImmunology
OncologyAllergyImmunology
2019English

Nestin as a Novel Therapeutic Target for Pancreatic Cancer via Tumor Angiogenesis

International Journal of Oncology
Cancer ResearchOncology
2012English

The Role of Calcineurin/Nfat in SFRP2 Induced Angiogenesis—A Rationale for Breast Cancer Treatment With the Calcineurin Inhibitor Tacrolimus

PLoS ONE
Multidisciplinary
2011English

On Exploring Hidden Structures Behind Cervical Cancer Incidence

Cancer Control
MedicineOncologyHematology
2018English

Therapeutic Delivery of miR-29b Enhances Radiosensitivity in Cervical Cancer

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2019English

LncRNA as a Therapeutic Target for Angiogenesis

Current Topics in Medicinal Chemistry
MedicineDrug Discovery
2017English

Cell Therapies for Therapeutic Angiogenesis: Back to the Bench

Vascular Medicine
MedicineCardiovascular MedicineCardiology
2009English

TEM8/ANTXR1 Blockade Inhibits Pathological Angiogenesis and Potentiates Tumoricidal Responses Against Multiple Cancer Types

Cancer Cell
Cancer ResearchOncologyCell Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy